News Industry News St. Jude Medical Announces European Launch of Smaller Quadripolar Pacing System September 20, 2011
News Industry News FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation September 08, 2011
News Daily News Low US Participation in NIH-Sponsored CVD Trials Cause for Concern Jason Kahn August 01, 2011
News Industry News Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure July 11, 2011
News Daily News BARC: New Bleeding Definitions Aim to Standardize Trial Endpoints L.A. McKeown June 17, 2011
News Industry News St. Jude Medical to Showcase PCI Optimization Technology and Structural Heart Portfolio at EuroPCR May 16, 2011
News Industry News Volcano to Highlight its Precision Guided Therapy Technologies at EuroPCR May 16, 2011
News Industry News St. Jude Medical Sponsored Study Determines FFR Can Improve Health while Reducing Economic Burden to German Healthcare System April 29, 2011
News Industry News St. Jude Medical Announces European Approval of Accent MRI Pacemaker System April 18, 2011
News Industry News Medtronic to Form a Single, Unified U.S. Cardiac and Vascular Group Sales Organization April 07, 2011
News Industry News Bayer’s Rivaroxaban Submitted for Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation in the US January 04, 2011
News Industry News Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis January 04, 2011
CME Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes
Partner Content The Role of IN.PACT™ Admiral™ in the Treatment of Complex Lesions: Medtronic November 2, 2021